New diagnostic biomarkers offer ray of hope for Alzheimer’s disease

Posted August 30th, 2012 by PCC STEM & filed under Health Sciences.

Alzheimer's disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin.

Comments are closed.